Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. AbbVie's annualizedGross Profit for the quarter that ended in Dec. 2023 was $34,388 Mil.
AbbVie's average Total Assets over the quarter that ended in Dec. 2023 was $135,466 Mil. Therefore, AbbVie's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 25.38%.
AbbVie Gross-Profit-to-Asset % Historical Data
The historical data trend for AbbVie's Gross-Profit-to-Asset % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of AbbVie's Gross-Profit-to-Asset %
For the Drug Manufacturers - General subindustry, AbbVie's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AbbVie's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, AbbVie's Gross-Profit-to-Asset % distribution charts can be found below:
* The bar in red indicates where AbbVie's Gross-Profit-to-Asset % falls into.
AbbVie Gross-Profit-to-Asset % Calculation
AbbVie's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Gross Profit data used here is four times the quarterly (Dec. 2023) data.
Gross-Profit-to-Asset % is displayed in the 30-year financial page.
AbbVie Gross-Profit-to-Asset % Related Terms
Thank you for viewing the detailed overview of AbbVie's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.
AbbVie is a pharmaceutical firm with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ABBV has been successfully added to your 